Evidence map›Paper›PMID 30258008›Full record

ArticleJournal of virology2018

Comparison of the Immunogenicities and Cross-Lineage Efficacies of Live Attenuated Peste des Petits Ruminants Virus Vaccines PPRV/Nigeria/75/1 and PPRV/Sungri/96.

Sophia Hodgson, Katy Moffat, Holly Hill, John T Flannery, Simon P Graham, Michael D Baron, Karin E Darpel

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Depletion of CD8Transboundary and emerging diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sophia HodgsonThe Pirbright Institute, Pirbright, Surrey, UK.
Katy MoffatThe Pirbright Institute, Pirbright, Surrey, UK.
Holly HillThe Pirbright Institute, Pirbright, Surrey, UK.
John T FlanneryThe Pirbright Institute, Pirbright, Surrey, UK.
Simon P GrahamThe Pirbright Institute, Pirbright, Surrey, UK.
Michael D Baron *The Pirbright Institute, Pirbright, Surrey, UK michael.baron@pirbright.ac.uk karin.darpel@pirbright.ac.uk.
Karin E Darpel *The Pirbright Institute, Pirbright, Surrey, UK michael.baron@pirbright.ac.uk karin.darpel@pirbright.ac.uk.
The Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L014203/1Biotechnology and Biological Sciences Research Council BBS/E/I/00001728Biotechnology and Biological Sciences Research Council BBS/E/I/00001858Biotechnology and Biological Sciences Research Council BBS/E/I/00002035Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007037Biotechnology and Biological Sciences Research Council BBS/E/I/00007039
6 · The paper itself

Abstract

Peste des petits ruminants (PPR) is a severe disease of goats and sheep that is widespread in Africa, the Middle East, and Asia. Several effective vaccines exist for the disease, based on attenuated strains of the virus (PPRV) that causes PPR. While the efficacy of these vaccines has been established by use in the field, the nature of the protective immune response has not been determined. In addition, while the vaccine derived from PPRV/Nigeria/75/1 (N75) is used in many countries, those developed in India have never been tested for their efficacy outside that country. We have studied the immune response in goats to vaccination with either N75 or the main Indian vaccine, which is based on isolate PPRV/India/Sungri/96 (S96). In addition, we compared the ability of these two vaccines, in parallel, to protect animals against challenge with pathogenic viruses from the four known genetic lineages of PPRV, representing viruses from different parts of Africa, as well as Asia. These studies showed that, while N75 elicited a stronger antibody response than S96, as measured by both enzyme-linked immunosorbent assay and virus neutralization, S96 resulted in more pronounced cellular immune responses, as measured by virus antigen-induced proliferation and interferon gamma production. While both vaccines induced comparable numbers of PPRV-specific CD8

Indexed as

AfricaAnimalsAntibodies, ViralAsiaCD8-Positive T-LymphocytesEvolution, MolecularGoatsIndiaPeste-des-Petits-RuminantsPeste-des-petits-ruminants virusPhylogenyPhylogeographySheepVaccinationVaccines, AttenuatedViral VaccinesAntibodies, ViralVaccines, AttenuatedViral Vaccinesimmune responselivestock diseasemorbillivirusprotectionvaccines

Identifiers

PMID30258008
PMCPMC6258957
OpenAlexW2893293860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.